kalshi Science and Technology

When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema?

Before 2028
Closes Jan 01, 2028 (525d) 24h volume 79 Open interest 73 Event When will the FDA approve Intellia Therapeutics' lonvo-z?
68%
implied YES probability
-4.0pp 24h

Price history

Last 14 days · High 70% · Low 54% · 7d -5.8pp
70%54%

Other outcomes in this event

Related stocks

Trade on Kalshi

Open on Kalshi
Frenzy Capital does not execute trades on prediction markets — we aggregate public order-book and trading data for analysis.

Prediction market data reflects speculative event probabilities, not guaranteed outcomes. This is not investment advice. See Terms §17.